Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors - AstraZeneca...

Published on 26 Feb 2024 on Benzinga

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors - AstraZeneca...

The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials by Zealand Pharma were published, pushing the Danish company’s shares 30% higher.

Zealand Pharma’s survodutide drug showed positive results in 83% of patients in Phase 2 trials being tested for a liver disease caused by excess fat cells called MASH, the company announced on Monday.

Read the rest of the article

NYSE.LLY price evolution

NYSE.CTLT price evolution

LSE.AZN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices

Dividend stocks trading at discounted prices can make for great investments if you're willing to ...

Motley Fool · via Yahoo Finance 15 Jan 2025

Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros’ Portfolio?

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In...

Insider Monkey · via Yahoo Finance 14 Jan 2025

3 Cheap Growth Stocks to Buy in 2025

For long-term investors, now may be a good time to reevaluate the contents of your portfolio to s...

Motley Fool · via Yahoo Finance 9 Jan 2025

Why Is AstraZeneca PLC (NASDAQ:AZN) Among the Best FTSE Dividend Stocks to Buy...

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 6 Jan 2025

Sweden shares lower at close of trade; OMX Stockholm 30 down 0.28% By...

Sweden shares lower at close of trade; OMX Stockholm 30 down 0.28%

Investing.com 31 Dec 2024

Emergent BioSolutions stock leverages NARCAN and vaccine sales for long-term...

Monday, H.C. Wainwright began covering Emergent BioSolutions Inc. (NYSE:EBS) with a Buy rating an...

Investing.com 30 Dec 2024

Is AstraZeneca PLC (AZN) Among the U.K. Dividend Champions for 2024?

We recently compiled a list of the U.K. Dividend Champions List: 2024 Rankings by Yield. In this...

Insider Monkey · via Yahoo Finance 30 Dec 2024

Is AstraZeneca PLC (AZN) Among the U.K. Dividend Aristocrats for 2024?

We recently compiled a list of the U.K. Dividend Aristocrats List: 2024 Rankings by Yield. In thi...

Insider Monkey · via Yahoo Finance 29 Dec 2024

Here's Why Astrazeneca (AZN) is a Strong Value Stock

Astrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmace...

Zacks · via Yahoo Finance 27 Dec 2024

AstraZeneca withdraws EU application for lung cancer drug By Investing.com

AstraZeneca PLC (LSE:LON:AZN), a pharmaceutical giant with a market capitalization of $203 billio...

Investing.com 27 Dec 2024

News

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors - AstraZeneca...

NYSE.LLY price evolution

NYSE.CTLT price evolution

LSE.AZN price evolution

Want to become a better investor?